# LRRC59

## Overview
LRRC59 is a gene that encodes the leucine-rich repeat-containing 59 protein, which is primarily involved in the regulation of mRNA translation on the endoplasmic reticulum (ER) membrane. This protein is categorized as a ribosome-binding protein and plays a crucial role in the spatial organization of mRNA translation, particularly for secretory and membrane proteins. LRRC59 interacts with various components of the signal recognition particle (SRP) machinery, translation factors, and RNA-binding proteins, indicating its involvement in the SRP pathway and compartmentalized mRNA translation (Hannigan2020Quantitative). Additionally, LRRC59 is implicated in modulating type I interferon (IFN) signaling, enhancing antiviral immune responses by stabilizing the DDX58 protein (Xian2019LRRC59). The gene's expression levels have been associated with various cancers, where it can act as either a protective factor or a promoter of tumor progression, depending on the cancer type (Li2020&lt; Chen2023Construction).

## Function
LRRC59 is a protein-coding gene that plays a significant role in mRNA translation on the endoplasmic reticulum (ER) membrane. It is involved in the spatial organization of mRNA translation, contributing to the synthesis of secretory and membrane proteins. LRRC59 interacts with components of the signal recognition particle (SRP) machinery, translation factors, and RNA-binding proteins, suggesting its involvement in the SRP pathway and compartmentalized mRNA translation (Hannigan2020Quantitative). 

The protein is known to bind ribosomes and may function as a non-translocon ribosome binding site, facilitating the translation of both cytosolic and secretory/membrane protein-encoding transcripts (Hannigan2020Quantitative). LRRC59 also interacts with stress granule proteins, indicating a role in mRNA regulation via stress granule assembly (Hannigan2020Quantitative). 

In addition to its role in protein synthesis, LRRC59 modulates type I interferon (IFN) signaling, particularly in antiviral immune responses. It stabilizes the DDX58 protein, preventing its autophagic degradation, thereby enhancing type I IFN signaling and promoting antiviral defense (Xian2019LRRC59).

## Clinical Significance
Alterations in the expression of the LRRC59 gene have been implicated in various cancers. In colorectal adenocarcinoma (COAD), LRRC59 expression is significantly elevated in tumor tissues compared to healthy tissues. Higher expression levels of LRRC59 are associated with better survival rates, suggesting it acts as a protective factor. Knockdown experiments indicate that reducing LRRC59 expression decreases cell viability and increases migration and invasion in COAD cell lines, highlighting its critical role in cell survival and behavior (Chen2023Construction).

In contrast, in lung adenocarcinoma (LUAD), overexpression of LRRC59 is linked to poor prognosis. High mRNA levels of LRRC59 correlate with worse overall survival in LUAD patients. Functional experiments demonstrate that knockdown of LRRC59 in lung cancer cell lines leads to reduced cell proliferation, colony formation, and cell cycle progression, specifically causing G1 phase arrest. This suggests that LRRC59 plays a significant role in promoting tumor progression in LUAD (p&gt; Overexpression; Li2020&lt).

LRRC59 also modulates type I interferon (IFN) signaling, particularly in antiviral immune responses. It acts as a positive regulator of DDX58/RIG-I-mediated type I IFN signaling, enhancing antiviral immune responses by stabilizing DDX58 and preventing its autophagic degradation (Xian2019LRRC59).

## Interactions
LRRC59 is involved in various protein interactions, particularly in the context of mRNA translation on the endoplasmic reticulum (ER) membrane. It interacts with components of the signal recognition particle (SRP) machinery, translation initiation factors, and RNA-binding proteins. Notable interacting proteins include SERPB1, DHX29, PRRC2C, SRP68, SRP72, SRP54, and RRBP1, which are part of the LRRC59 interactome (Hannigan2020Quantitative). LRRC59 is also associated with ribosomal proteins and other rough ER proteins such as SEC61B, SSR4, and SRPRB, which are involved in translocon and SRP receptor functions (Sawyer2023A).

The protein is implicated in the spatial organization of mRNA translation on the ER, potentially by interacting with the SRP receptor or SRP to recruit mRNA/ribosome/nascent peptide complexes to the ER membrane. It may also bind translationally active ribosomes or facilitate mRNA translation initiation by binding ribosomal subunits and initiation factors (Hannigan2020Quantitative). Additionally, LRRC59 interacts with proteins associated with stress granules, indicating a role in fine-tuning protein synthesis in response to cellular stress (Hannigan2020Quantitative). These interactions suggest that LRRC59 plays a critical role in the regulation of secretory and membrane protein synthesis on the ER.


## References


1. (Hannigan2020Quantitative) Quantitative proteomics links the LRRC59 interactome to mRNA translation on the ER membrane. This article has 1 citations.

2. (Sawyer2023A) A Flat Protein Complex Shapes Rough ER Membrane Sheets. This article has 2 citations.

[3. (Chen2023Construction) Hua Chen, Ting Zhao, Jianing Fan, Zhiqiang Yu, Yiwen Ge, He Zhu, Pingping Dong, Fu Zhang, Liang Zhang, Xiangyang Xue, and Xiaoming Lin. Construction of a prognostic model for colorectal adenocarcinoma based on zn transport-related genes identified by single-cell sequencing and weighted co-expression network analysis. Frontiers in Oncology, September 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1207499, doi:10.3389/fonc.2023.1207499. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1207499)

[4. (Xian2019LRRC59) Huifang Xian, Shuai Yang, Shouheng Jin, Yuxia Zhang, and Jun Cui. Lrrc59 modulates type i interferon signaling by restraining the sqstm1/p62-mediated autophagic degradation of pattern recognition receptor ddx58/rig-i. Autophagy, 16(3):408â€“418, May 2019. URL: http://dx.doi.org/10.1080/15548627.2019.1615303, doi:10.1080/15548627.2019.1615303. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2019.1615303)